Leadership Change LifeScan has appointed a new CEO, Jonathan Salkin, in May 2026, signaling potential strategic shifts and new growth initiatives worth exploring for partnerships, funding conversations, and product expansion opportunities.

Strategic Partnerships A transformational partnership with i-SENS to launch the OneTouch continuous glucose monitoring system in early 2026 indicates openness to collaboration and co-development; sales teams should pursue joint go-to-market strategies, integration opportunities, and distribution arrangements.

Product Expansion Recent launch of the OneTouch continuous glucose monitoring system and OneTouch Amazon storefront expansion point to acceleration in product portfolio and direct-to-consumer channels; explore opportunities for supply chain enhancements, device integration, and channel partnerships.

Small but Targeted Company size (51-200 employees) and revenue under $1M suggest a high-growth, early-stage profile with potential for strategic investments, channel partnerships, and SDG-friendly healthcare technology collaborations that can scale with enterprise clients.

Tech Enablement Adoption of analytics and enterprise tools (Power BI, Tableau, Salesforce, iCIMS, Drupal) indicates a technology-forward environment; target opportunities around data integration, customer insight platforms, and CRM-driven sales enablement to improve go-to-market efficiency.